PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

The Possible Sales Projection Part 2 - The next 4 years, page-15

  1. 4,296 Posts.
    lightbulb Created with Sketch. 6816
    PharmD - Correct - I've heard 50K isn't out of the question for our MPS solution. ERT costs can come out to be closer to $1 Million per annum.
    ERT does nothing for pain relief in their joints. We might work with them together. eg Biomarin is the major ERT provider from what I know.


    free2nap - I guess you are right, there might be some snooping aorund ("Good Morning" to any that are!), though you'd think they would have many more other avenues to really research us. The big ones would be meeting with the PAR team to sus it out. cool.png
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.